Hamilton Lane Advisors LLC Homology Medicines, Inc. Transaction History

Hamilton Lane Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$14.74 - $22.28 $336,528 - $508,674	-22,831 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$18.35 - $30.34 $418,948 - $692,692	22,831 New	22,831 $447,000
Q4 2018 Jan 23, 2019	SELL	$18.39 - $26.3 $1.86 Million - $2.67 Million	-101,405 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$15.54 - $22.86 $1.58 Million - $2.32 Million	101,405 New	101,405 $2,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.